See more : PhoneBrasil International, Inc. (PHBR) Income Statement Analysis – Financial Results
Complete financial analysis of Lasa Supergenerics Limited (LASA.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Lasa Supergenerics Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Lifestyle Global Enterprise Inc. (8066.TWO) Income Statement Analysis – Financial Results
- Huang Long Development Co.,Ltd. (3512.TWO) Income Statement Analysis – Financial Results
- Yippy, Inc. (YIPI) Income Statement Analysis – Financial Results
- Adamis Pharmaceuticals Corporation (ADMP) Income Statement Analysis – Financial Results
- Anfu CE LINK Limited (300787.SZ) Income Statement Analysis – Financial Results
Lasa Supergenerics Limited (LASA.NS)
About Lasa Supergenerics Limited
Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products primarily in India. It offers veterinary and other API products, anthelmintic products, animal feed ingredients, and reagents for therapeutic use. The company also exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.04B | 1.30B | 1.37B | 2.02B | 1.67B | 1.70B | 2.44B | 2.00B | 0.00 |
| Cost of Revenue | 756.40M | 1.06B | 920.16M | 1.14B | 955.14M | 1.29B | 1.74B | 1.34B | 0.00 |
| Gross Profit | 286.95M | 234.54M | 451.11M | 886.86M | 717.43M | 406.52M | 690.81M | 661.09M | 0.00 |
| Gross Profit Ratio | 27.50% | 18.10% | 32.90% | 43.82% | 42.89% | 23.97% | 28.37% | 33.11% | 0.00% |
| Research & Development | 1.32M | 1.02M | 2.02M | 3.74M | 3.38M | 1.64M | 2.15M | 1.70M | 0.00 |
| General & Administrative | 32.16M | 35.71M | 43.06M | 39.96M | 19.46M | 19.05M | 18.27M | 3.07M | 0.00 |
| Selling & Marketing | 9.25M | 20.98M | 19.20M | 29.69M | 31.16M | 9.84M | 9.60M | 13.09M | 0.00 |
| SG&A | 41.41M | 56.68M | 62.27M | 69.65M | 50.62M | 28.89M | 27.87M | 16.16M | 0.00 |
| Other Expenses | 245.55M | 18.05M | 109.00K | 87.00K | 486.74M | 3.18M | 423.44M | 275.84M | 0.00 |
| Operating Expenses | 286.95M | 434.66M | 426.39M | 572.45M | 559.82M | 484.28M | 459.68M | 292.00M | 0.00 |
| Cost & Expenses | 1.04B | 1.50B | 1.35B | 1.71B | 1.51B | 1.77B | 2.20B | 1.63B | 0.00 |
| Interest Income | 419.00K | 310.00K | 466.00K | 490.00K | 2.32M | 37.99M | 34.14M | 2.72M | 0.00 |
| Interest Expense | 19.74M | 41.61M | 245.00K | 16.76M | 72.96M | 107.93M | 94.53M | 1.10M | 0.00 |
| Depreciation & Amortization | 106.73M | 134.19M | 145.11M | 158.24M | 173.39M | 193.09M | 181.67M | 76.88M | 0.00 |
| EBITDA | -65.08M | -246.86M | 84.12M | 472.65M | 301.79M | 113.52M | 412.79M | 457.32M | 0.00 |
| EBITDA Ratio | -6.24% | -3.70% | 11.49% | 23.25% | 19.17% | 8.36% | 17.60% | 18.24% | 0.00% |
| Operating Income | -84.31M | -180.99M | 47.47M | 314.41M | 155.83M | -78.40M | 231.24M | 369.09M | 0.00 |
| Operating Income Ratio | -8.08% | -13.97% | 3.46% | 15.54% | 9.32% | -4.62% | 9.50% | 18.49% | 0.00% |
| Total Other Income/Expenses | -106.81M | -422.65M | -108.86M | -417.01M | -108.38M | -81.42M | -78.75M | -359.58M | 0.00 |
| Income Before Tax | -191.13M | -422.65M | -62.10M | 294.91M | 47.36M | -161.03M | 152.33M | -30.16M | 0.00 |
| Income Before Tax Ratio | -18.32% | -32.62% | -4.53% | 14.57% | 2.83% | -9.50% | 6.26% | -1.51% | 0.00% |
| Income Tax Expense | 26.18M | -36.44M | -8.42M | 67.14M | 11.08M | -40.72M | 28.93M | -23.91M | 0.00 |
| Net Income | -217.31M | -386.21M | -53.67M | 227.78M | 36.28M | -120.31M | 123.40M | -6.25M | 0.00 |
| Net Income Ratio | -20.83% | -29.81% | -3.91% | 11.25% | 2.17% | -7.09% | 5.07% | -0.31% | 0.00% |
| EPS | -4.34 | -7.71 | -1.07 | 5.60 | 0.89 | -5.26 | 5.43 | -0.30 | 0.00 |
| EPS Diluted | -4.34 | -7.71 | -1.07 | 5.60 | 0.89 | -5.26 | 5.43 | -0.30 | 0.00 |
| Weighted Avg Shares Out | 50.07M | 50.10M | 50.10M | 40.67M | 40.67M | 22.86M | 22.73M | 20.63M | 22.84M |
| Weighted Avg Shares Out (Dil) | 50.10M | 50.10M | 50.10M | 40.67M | 40.67M | 22.86M | 22.73M | 20.63M | 22.84M |
Source: https://incomestatements.info
Category: Stock Reports